Zn-Telomir

N/A

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameZn-Telomir
Drug Alias NameN/A
ClassificationRadiation-emitting products > Nuclides > ZincSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTelomir Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesTelomir Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A